Related Experiment Video
Updated: Apr 3, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics
Adam L Hersh1, Jeffrey S Gerber2, Lauri A Hicks3
1Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City;
Insights
Physicians rarely prescribe fluoroquinolones to children, unlike adults, due to safety concerns. This perception of harm influences antibiotic choices and impacts antibiotic stewardship efforts.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Infectious Diseases
Background:
- Fluoroquinolones are frequently prescribed for adults but rarely for pediatric patients.
- A significant disparity exists in fluoroquinolone prescribing patterns between adult and pediatric populations.
- This difference may stem from physician perceptions regarding potential patient harm.
Purpose of the Study:
- To investigate the reasons behind the divergent use of fluoroquinolones in adult versus pediatric care.
- To understand the influence of perceived direct patient harm on antibiotic prescribing decisions.
- To explore the implications of these perceptions for effective antibiotic stewardship.
Main Methods:
- Analysis of antibiotic prescribing data in ambulatory care settings.
- Review of physician attitudes and perceptions regarding fluoroquinolone safety in different age groups.
- Qualitative or quantitative assessment of factors influencing antibiotic selection.
Main Results:
- Fluoroquinolones represent the leading antibiotic class for adults in outpatient settings.
- Conversely, fluoroquinolones are the least frequently prescribed antibiotic class for children.
- Physician perception of direct patient harm is a key factor in this prescribing disparity.
Conclusions:
- Physician perception of harm significantly impacts antibiotic prescribing for pediatric patients.
- The differing use of fluoroquinolones highlights the need to address safety concerns in pediatric antibiotic decision-making.
- Understanding these perceptions is crucial for improving antibiotic stewardship and ensuring appropriate medication use.
Abstract:
The use of fluoroquinolones differs dramatically between adult and pediatric patients. For adults, they are the leading class of antibiotics prescribed in ambulatory care visits whereas in children, they are the least frequently prescribed class. The reasons for this difference in practice likely relate to perceptions of their potential for harm. This highlights the impact of physicians' perception of direct patient harm in antibiotic decision making which has implications for antibiotic stewardship.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Mechanism of Antibiotic Resistance in MRSA
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution

